Manual Therapy on Activation of the Descending Pain Inhibitory System in Patients With Knee Osteoarthritis
MulliganKnee
1 other identifier
interventional
28
1 country
1
Brief Summary
Introduction: Knee osteoarthritis is a clinical syndrome which is characterized by pain. It has been shown to cause changes in the nervous system leading to central sensitization. There are factors involved in this disease such as sex (female) or obesity. The most recommended therapy is physical therapy, but manual therapy is needed to cause changes in central sensitization. Methods: Experimental, prospective, parallel and longitudinal double-blind study, in which two groups are performed: group A (AP mobilizations) and group B (Mulligan's mobilizations). Different variables and questionnaires were used: pressure pain threshold, temporal summation, pain modulation, central sensitization inventory, WOMAC, Times Up \& GO, numerical rating scale, Beck, STAI, kinesiophobia, catastrophism, Barthel and mini- cognitive test
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
April 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2020
CompletedJuly 27, 2020
July 1, 2020
15 days
February 3, 2020
July 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in Mechanical Hyperalgesia
To measure the pain thresholds by pressure we use an algometer with a surface area of 1cm2 applying it perpendicularly to the skin with a speed of 1 kg / cm2 / s until the patient indicates that the first sensation of pain appears, ceasing at that moment the pressure made. Three measurements will be recorded with an interval of 30 seconds to avoid a temporal sum effect. The measurement will be taken in a distal region of the ipsilateral carpal long radial extender (a point distal to the carpal long radial extender (5cm distal to the lateral epicondyle)) and in the peripatellar region the standard UDP assessment protocol will be used. In the patellar region two sites will be evaluated (3cm medial and lateral to the midpoint of the lateral and medial patella border). A minimum change of 1.62-1.53 kg / cm2 is required for the result to be clinically significant.
Change from Baseline Mechanical Hyperalgesia at 4th sessions
Changes in Temporal Summation
First the pressure pain thresholds are measured in the lateral area to the patella. Then 10 consecutive pulses are performed in the same locations to provoke the temporal sum, increasing the pressure by 2kg/s and maintaining it for 1 second (followed by 1 second of rest) in each pulse. The intensity of the pain is evaluated at the 1st, 5th and 10th pulse, by means of a numerical scale of the pain (0 being painless and 10 being the maximum pain imaginable).
Change from Baseline Mechanical Hyperalgesia at 4th sessions
Changes in Conditioned pain modulation
First, pressure pain stimulus (test stimulus) will be conducted in the lateral area to the patella. Second, occlusion cuff will be inflated around the arm of patient until the patient feeling a painful intensity (conditioned stimulus) of 6/10. Finally, after 30 seconds the stimulus will be done. The difference in the mean value of the initial algometry with the mean value of algometry during the conditioning stimulus will indicate the state of the descending pain inhibitory system.
Change from Baseline Mechanical Hyperalgesia at 4th sessions
Secondary Outcomes (10)
Central sensitization inventory
Baseline
WOMAC Questionnaire
Baseline
Test Time Up & Go
Change from Baseline Mechanical Hyperalgesia at 1 month
Numerical rating scale (NRS)
Change from Baseline Mechanical Hyperalgesia at 4th sessions
Beck Depression Inventory (BDI)
Baseline
- +5 more secondary outcomes
Study Arms (2)
Experimental mobilization: Mulligan
EXPERIMENTALMobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.
Control mobilization: AP Maitland
ACTIVE COMPARATORThe joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.
Interventions
Mobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.
The joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.
Eligibility Criteria
You may qualify if:
- Knee pain diagnosed with osteoarthritis of the knee using the criteria of the American College of Rheumatology
- Low or no response to pain medication for osteoarthritis knee pain.
You may not qualify if:
- Suffer from any disorder, syndrome or disease that may cause myofascial or neuropathic pain in the lower limbs, such as lumbar radiculopathy, meralgia paresthetica or saphenous nerve entrapment.
- Infiltration with steroids or local anaesthetics during the year prior to the patient's participation in the study or during follow-up.
- History of previous lower extremity or lumbopelvic surgery.
- Ingestion of substances of abuse that may interfere with treatment.
- Contraindications to perform joint therapy mobilizations.
- Previous diagnosis of myopathy or neuropathy (lumbo-sacral plexus)
- Cognitive deficit manifested in the clinical history (Alzheimer, dementia).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Rey Juan Carlos
Alcorcón, Madrid, 28922, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josué Fernández Carnero, Phd
Universidad Rey Juan Carlos
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Profesor
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 5, 2020
Study Start
April 30, 2020
Primary Completion
May 15, 2020
Study Completion
June 10, 2020
Last Updated
July 27, 2020
Record last verified: 2020-07